• Search
  • Login
  • Register
Menu
  • BJH
  • Home
  • News
  • CongressUpdate
  • Guidelines
  • Specials
  • Links
All
  • All
  • BJH articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > Clinical trials

Category

All
  • General
  • Healthy Living
  • Pharma News
  • Health of Tomorrow
  • Viewpoints
  • Art Corner
  • Fundraising
  • Prevention
  • Science
  • Clinical trials
  • Clinical practice
  • Corona
  • Medical Research
  • Health Innovation
  • Art on View
  • Podcasts
  • Therapy
  • Editor's pick
  • Covid-19

Clinical trials

A+AVD superior to ABVD for the first-line treatment of newly diagnosed stage III or IV Hodgkin...

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Highlights in chronic lymphocytic leukaemia
  • Highlights in chronic myeloid leukaemia
  • Highlights in lymphoma
  • Long-term outcomes of isatuximab in high-risk multiple myeloma
  • Highlights in multiple myeloma
  • Navigating secondary acute myeloid leukaemia in 2023
  • Highlights in acute myeloid leukaemia and myelodysplastic syndromes
  • Highlights in acute lymphoblastic leukaemia
  • New haematology reimbursements in Belgium
Clinical trials

Run To Kick benefits Belgian children with cancer more than ever before

Read more
Clinical trials

FDA approves pemigatinib for myeloid/lymphoid neoplasms patients with altered FGFR

Read more
Clinical trials

Adding elotuzumab to lenalidomide and dexamethasone does not improve PFS in patients with newl...

Read more
Clinical trials

LISO-CEL SHOWS SUPERIOR EFFICACY VS. STANDARD OF CARE AS SECOND-LINE TREATMENT FOR PRIMARY REF...

Read more
Clinical trials

Adding ibrutinib to bendamustine and rituximab prolongs progression-free survival in older pat...

Read more
Clinical trials

Three-agent regimen provides ‘unprecedented’ PFS benefit in patients with relapsed multipl...

Read more
Clinical trials

Circulating tumour cells and disease staging in newly diagnosed multiple myeloma patients

Read more
Clinical trials

PTCy plus TK is safe and effective in reducing GVHD in older patients with blood cancers

Read more
Previous 2 3 4 5 6 7 8 Next
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJH
  • Advertisements & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJH is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJH 2023